Both medications work through different mechanisms to lower blood glucose levels, and when used in combination, they may provide complementary glycaemic control for patients who have not achieved adequate results with a single agent
Victoza (liraglutide) prescribing information
Tirzepatide activates both pathways, which explains its enhanced effectiveness for both weight loss and metabolic health improvements
New midstage trial data supporting Pfizer's berobenatide suggest that monthly dosing could significantly improve treatment persistence compared to currently available weekly regimens like semaglutide and tirzepatide
Patients should maintain their usual eating patterns on the first day unless otherwise instructed by their healthcare provider
To date, 5 types of DPP-4 inhibitors are approved for clinical use: sitagliptin, saxagliptin, vildagliptin, linagliptin and alogliptin